Skip to main content

Myocardial Infarction- Etiology, Pathogenesis, Clinical Diagnosis and Management!

MYOCARDIAL INFARCTION

Definition:

  • Myocardial Infarction is defined as " a diseased condition which is caused by reduced blood flow to the coronary artery due to atherosclerosis and occlusion of artery by embolus or thrombus."

Myocardial Infarction (or Heart attack) is the irreversible damage of myocardial tissue due to prolonged ischemia or hypoxia.

Universally accepted definition of MI: Evidence of myocardial necrosis in consistent with the myocardial ischemia, in which case any of the following meets the diagnosis of Myocardial Infarction.

  1. Evidence rises and/or fall of cardiac biomarkers (preferably troponin).
  2. ECG changes indicative of new ischemia (new ST-T changes or new left bundle branch block)
  3. Development of pathological Q waves.
  4. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality.


Etiology:

  • Tobacco smoking
  • Diabetes Mellitus
  • Age
  • Hypertension
  • Obesity
  • Gender
  • Stress
  • Drug abuse
  • Alcohol consumption
  • Family history of ischemic heart disease (IHD)
  • Chronic Kidney Disease (CKD)
  • Hyperhomocystenima
  • Hyperlipoproteinemia

Etiopathogenesis:

  1. Acute plaque rupture
  2. Myocardial ischemia
  3. Non-atherosclerotic cause
  4. Transmural v/s subendocardial infarcts
  5. Role of platelets

 Pathophysiology

Clinical Presentation:

  • Chest pain
  • Dyspnea
  • Fatigue
  • Sweating
  • Weakness
  • Nausea
  • Vomiting
  • Light headache
  • Palpitation
  • Anxiety
  • Sleeplessness
  • Hypertension
  • Hypotension
  • Arrythmias

Complications:

  • Arrythmias
  • Cardiogenic shock
  • Congestive Heart failure
  • Thromboembolism
  • Pericarditis

Diagnosis/Investigation:

  1. Clinical Features: Apprehension, Fever, Pain, Shock, Indigestion.
  2. Serum cardiac Markers: 
  • Creatinine phosphokinase (CK)
  • Lactic dehydrogenase (LDH)
  • Cardiac specific troponins (CTN)

      3. ECG changes: ST segment elevation, T wave inversion, Appearance of wide deep Q wave.

      4.Other Tests: MRI, Angiography, Position emission tomography (PET scan). Chest X-ray, Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP).

Management:

1.Non-Pharmacological Treatment:

  1. Counselling and education to patients.
  2. Alcohol consumption cessation.
  3. Smoking cessation
  4. Lifestyle measurement
  5. Diet and nutrition
  6. Salt Restriction

2.Pharmacological Treatment:

  1. Anti-Thrombolytic Therapy: 

  • Antiplatelets-to reduce the aggregation of platelets such as Aspirin, Clopidogrel, Ticagrelor.
  • Anti-coagulants- that reduces the risk of thromboembolic complication and prevents reinfarction in the absence of reperfusion therapy. 

      2. Anti-hypertensive agents:

  • Glyceryl trinitrate sublingual, IV nitrates

      3. Lipid Lowering Agents:

  • Reduction of cholesterol through diet and drugs helps reducing morbidity and mortality.

      4. Vasodilators: 

  • Beta blockers

      5. Others:

  • such as Analgesics, IV Opiates (morphine sulphate or diamorphine 2.5-5mg), IV anti-emetics (initially metoclopramide 10mg), Anti-ulcers, Antidepressants

      6. Reperfusion Therapy:

  • Depending on the type of MI, outcome of reperfusion therapy varies: 

          NSTEMI (Non-demonstrable benefit)

          STEMI (Restores coronary artery patency, improves ventricular function and improves survival)

      7. Percutaneous Coronary Intervention (PCI)

      8. Thrombolysis: 

  • It reduces hospital mortality by 20-50%. 
  • Alteplase (human tissue plasminogen activator). over 90 minutes (15mg bolus dose), followed by 0.75mg/kg bodyweight not exceeding 50mg over 30 minutes. Then 0.5mg/kg body weight, not exceeding 35mg over 60 minutes. 
  • This has better survival rate than other thrombolytics.




Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Non-Pharmacological Therapy--MNT!

 NON PHARMACOLOGICAL THERAPY  MNT Glycemic Index Dietary supplements Weight measurements Physical Activity Psychological assessment Immunizations 1. MEDICAL NUTRITION THERAPY (MNT)  " Medical Nutrition Therapy (MNT) is a term used by the ADA to describe the optimal condition of caloric intake with other aspects of diabetes therapy (Insulin, Exercise, Weight loss)". The ADA has issued recommendations for three types of MNT: Primary prevention measures of MNT are directed at preventing or delaying the onset of type 2 Diabetes in high-risk individuals (obese or with pre-diabetes) by promoting weight reduction. Secondary prevention measures of MNT are directed at preventing or delaying-related complications in diabetic individuals by improving glycemic control. Tertiary prevention measures of MNT are directed at managing diabetes-related complications (cardiovascular disease, neuropathy) in diabetic individuals. Despite the popular notion, there is not any " Diabetic diet...
Post a Comment
Read more

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...
Post a Comment
Read more

Medical Emergency- Cardiac Arrest and Basic Life Support (BLS)!

  MEDICAL EMERGENCY- CARDIAC ARREST AND BASIC LIFE SUPPORT Definition: " Cardiac Arrest is a medical emergency requiring a systematic approach". Early recognition must be followed by prompt, effective application of Basic Life Support (BLS) techniques to sustain the patient until Advanced Life Support (ALS) capabilities are available. Management: The management of Cardiac Arrest is a 4-step approach: Recognition and Assessment BLS Advanced Cardiovascular Life Support (ACLS) Post-resuscitation Care 1. RECOGNITION AND ASSESMENT Verify that the respiration and circulation have ceased: Loss of consciousness Loss of functional ventilation (respiratory arrest or inadequate respiratory effort) Loss of functional perfusion (No pulse). 2. BASIC LIFE SUUPORT (BLS) The goal in cardiac arrest is the restoration of spontaneous circulation (ROSC). The first step towards achieving this ROSC goal is prompt initiation of BLS, where the goal is to rapidly and effectively perfuse the tissues wi...
Post a Comment
Read more